We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DATA
676
DELISTED
Tableau Software, Inc.
DATA
| $3.06M | 0.01% |
50,000
| – | – |
|
677
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
| $3.06M | 0.01% |
62,580
+400
| +0.6% | +$19.5K |
|
|
GNCA
678
DELISTED
Genocea Biosciences, Inc.
GNCA
| $3.06M | 0.01% |
73,258
-2,734
| -4% | -$132K |
|
|
AVXS
679
DELISTED
AveXis, Inc. Common Stock
AVXS
| $3.02M | 0.01% |
36,708
-1,335
| -4% | -$100K |
|
680
Invesco S&P 500 Low Volatility ETF
SPLV
$7.08B
| $3M | 0.01% |
67,190
+90
| +0.1% | +$3.99K |
|
681
Central Garden & Pet Co
CENT
$2.51B
| $3M | 0.01% |
118,013
-16,750
| -12% | -$453K |
|
682
Q2 Holdings
QTWO
$3.75B
| $2.99M | 0.01% |
81,000
+14,000
| +21% | +$531K |
|
|
PGRE
683
DELISTED
Paramount Group
PGRE
| $2.99M | 0.01% |
186,970
-184,042
| -50% | -$2.99M |
|
|
CXP
684
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.97M | 0.01% |
132,812
-97,200
| -42% | -$2.16M |
|
685
PTC Therapeutics
PTCT
$5.48B
| $2.96M | 0.01% |
161,600
+151,100
| +1,439% | +$2.04M |
|
|
SWN
686
DELISTED
Southwestern Energy Company
SWN
| $2.93M | 0.01% |
482,500
+426,800
| +766% | +$2.95M |
|
|
RATE
687
DELISTED
Bankrate Inc
RATE
| $2.93M | 0.01% |
227,799
+13,599
| +6% | +$146K |
|
688
Advanced Energy
AEIS
$10B
| $2.92M | 0.01% |
45,200
| – | – |
|
|
CAVM
689
DELISTED
Cavium, Inc.
CAVM
| $2.92M | 0.01% |
47,000
+7,000
| +18% | +$489K |
|
690
Invesco S&P International Developed Low Volatility ETF
IDLV
$334M
| $2.9M | 0.01% |
89,850
-800
| -0.9% | -$25.4K |
|
|
FSTX
691
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.89M | 0.01% |
+53,431
| New | +$2.47M |
|
|
WDR
692
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $2.88M | 0.01% |
152,740
-4,800
| -3% | -$84.3K |
|
|
ORBK
693
DELISTED
Orbotech Ltd
ORBK
| $2.86M | 0.01% |
87,620
+2,524
| +3% | +$85.6K |
|
694
Marathon Petroleum
MPC
$115B
| $2.85M | 0.01% |
54,520
+816
| +2% | +$42.2K |
|
695
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
| $2.83M | 0.01% |
63,692
| – | – |
|
696
SLR Investment Corp
SLRC
$658M
| $2.82M | 0.01% |
129,001
-11,500
| -8% | -$254K |
|
697
International Paper
IP
$18B
| $2.81M | 0.01% |
52,486
+9,279
| +21% | +$469K |
|
698
Arbutus Biopharma
ABUS
$1B
| $2.81M | 0.01% |
781,267
-27,862
| -3% | -$95.9K |
|
699
Onto Innovation
ONTO
$12B
| $2.81M | 0.01% |
111,000
-6,000
| -5% | -$169K |
|
|
CY
700
DELISTED
Cypress Semiconductor
CY
| $2.8M | 0.01% |
205,000
+25,000
| +14% | +$340K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.